Adult T-cell Leukemia/lymphoma
Last Posted: Aug 26, 2021
- Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Sakamoto Yuma, et al. British journal of haematology 2021 8
- Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next-Generation Sequencing are associated with disease progression in a North American Adult T-Cell Leukemia/Lymphoma cohort.
Zhang Xi, et al. International journal of laboratory hematology 2021 5
- Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma.
Kataoka Keisuke et al. Journal of clinical and experimental hematopathology : JCEH 2020 Aug
- Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma.
Zing Natalia Pin Chuen et al. Oncology (Williston Park, N.Y.) 2018 Aug 32(8)
- North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.
Shah Urvi A, et al. Blood 2018 8
- Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.
Kataoka Keisuke, et al. Blood 2017 10
- Human T-cell leukemia virus type I Tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: Different distributions compared with mainland Japan and the potential value for the prognosis of aggressive adult T-cell leukemia/lymphoma.
Sakihama Shugo, et al. Leukemia research 2017 8 18-24
- TET2 Mutation in Adult T-Cell Leukemia/Lymphoma.
Shimoda Kazuya, et al. Journal of clinical and experimental hematopathology : JCEH 2015 0 (3) 145-9
- Adult T-cell leukemia/lymphoma
From NCATS Genetic and Rare Diseases Information Center
- Missense mutation with/without nonsense mutation of the p53 gene is associated with large cell morphology in human malignant lymphoma.
Mitani S, et al. Pathology international 2007 7 (7) 430-6
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.